← Companies|Zevra Therapeutics
ZV

Zevra Therapeutics

ZVRA·NASDAQCelebration FLFounded 200650 employees
Small CapbiotechPublicRare DiseaseNeurology
Platform: Rare Neuro
Market Cap
$0.3B
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (ZVRA)
Loading ZVRA stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
TeracilimabZVR-766Phase 2/31Cell TherapyTIGITCAR-T CD19FLMM
MirisotorasibZVR-1717Phase 1/21Gene TherapyPRMT5ALKiHemophilia ACeliac
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (1)
2028-10-01
Mirisotorasib Ph2 Data
Celiac
Ph2 Data